T cell immunotherapy workflow improvements for clinical-grade manufacturing
Cell-based treatments are life-saving therapies with the potential to offer cures for cancers and other diseases.
Cell-based treatments are life-saving therapies with the potential to offer cures for cancers and other diseases.
For many other types of measurement, close agreement between instruments is achieved by calibration to a reference standard. Some examples include the calibration of a group of analytical balances to a single reference mass and calibration of pH meters to a precisely prepared buffer solution.
Researchers highlight the need for large-scale screening of cytotoxic cells and their ability to kill target cell lines in both a 2D and 3D fashion.
Webinar on Demand: Accurate and consistent cell counting methods for development and manufacturing of CAR-T under GMP/GLP conditions.
Watch the demo on demand: Modern Cell-based Assays for Cell and Gene Therapy Using Image Cytometry
Detection of novel CD276-CAR NK-92 mediated cytotoxicity of neuroblastoma tumor spheroids using plate-based image cytometry
In this webinar, we highlight a variety of assays to support the development of cell therapies for solid tumors.
Nexcelom founder and CTO, Dr. Jean Qiu, describes 3 major reasons why we partner with global and local research organizations to streamline CAR-T workflow.
Q & A regarding the crucial need for accurate and consistent cell counting methods for development and manufacturing of CAR-T under GMP/GLP conditions.
What is adoptive cell transfer therapy? What cells are commonly used? What are the counting and viability methods for these cell types?